Literature DB >> 16466916

Synthesis and biological activity of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 2: 2'-substituted triclosan derivatives.

Joel S Freundlich1, Min Yu, Edinson Lucumi, Mack Kuo, Han-Chun Tsai, Juan-Carlos Valderramos, Luchezar Karagyozov, William R Jacobs, Guy A Schiehser, David A Fidock, David P Jacobus, James C Sacchettini.   

Abstract

2'-Substituted analogs of triclosan have been synthesized to target inhibition of the key malarial enzyme Plasmodium falciparum enoyl acyl carrier protein reductase (PfENR). Many of these compounds exhibit good potency (EC50<500 nM) against in vitro cultures of drug-resistant and drug-sensitive strains of the P. falciparum parasite and modest (IC50=1-20 microM) potency against purified PfENR enzyme. Compared to triclosan, this survey of 2'-substituted derivatives has afforded gains in excess of 20- and 30-fold versus the 3D7 and Dd2 strains of parasite, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16466916     DOI: 10.1016/j.bmcl.2006.01.051

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

1.  Structural and enzymatic analyses reveal the binding mode of a novel series of Francisella tularensis enoyl reductase (FabI) inhibitors.

Authors:  Shahila Mehboob; Kirk E Hevener; Kent Truong; Teuta Boci; Bernard D Santarsiero; Michael E Johnson
Journal:  J Med Chem       Date:  2012-06-08       Impact factor: 7.446

2.  An update on the rapid advances in malaria parasite cell biology.

Authors:  Isabelle Coppens; David J Sullivan; Sean T Prigge
Journal:  Trends Parasitol       Date:  2010-04-09

3.  Targeting the Lipid Metabolic Pathways for the Treatment of Malaria.

Authors:  Choukri Ben Mamoun; Sean T Prigge; Henri Vial
Journal:  Drug Dev Res       Date:  2010-02       Impact factor: 4.360

4.  Structural and biological evaluation of a novel series of benzimidazole inhibitors of Francisella tularensis enoyl-ACP reductase (FabI).

Authors:  Shahila Mehboob; Jinhua Song; Kirk E Hevener; Pin-Chih Su; Teuta Boci; Libby Brubaker; Lena Truong; Tina Mistry; Jiangping Deng; James L Cook; Bernard D Santarsiero; Arun K Ghosh; Michael E Johnson
Journal:  Bioorg Med Chem Lett       Date:  2015-01-29       Impact factor: 2.823

5.  Design and synthesis of aryl ether inhibitors of the Bacillus anthracis enoyl-ACP reductase.

Authors:  Suresh K Tipparaju; Debbie C Mulhearn; Gary M Klein; Yufeng Chen; Subhasish Tapadar; Molly H Bishop; Shuo Yang; Juan Chen; Mahmood Ghassemi; Bernard D Santarsiero; James L Cook; Mary Johlfs; Andrew D Mesecar; Michael E Johnson; Alan P Kozikowski
Journal:  ChemMedChem       Date:  2008-08       Impact factor: 3.466

6.  Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.

Authors:  Gustavo A Afanador; Stephen P Muench; Martin McPhillie; Alina Fomovska; Arne Schön; Ying Zhou; Gang Cheng; Jozef Stec; Joel S Freundlich; Hong-Ming Shieh; John W Anderson; David P Jacobus; David A Fidock; Alan P Kozikowski; Colin W Fishwick; David W Rice; Ernesto Freire; Rima McLeod; Sean T Prigge
Journal:  Biochemistry       Date:  2013-12-13       Impact factor: 3.162

7.  Molecular modeling studies, synthesis, and biological evaluation of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR) inhibitors.

Authors:  Varun A Morde; Mushtaque S Shaikh; Raghuvir R S Pissurlenkar; Evans C Coutinho
Journal:  Mol Divers       Date:  2009-04-04       Impact factor: 2.943

8.  Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.

Authors:  Lorillee C Tallorin; Jacob D Durrant; Quynh G Nguyen; J Andrew McCammon; Michael D Burkart
Journal:  Bioorg Med Chem       Date:  2014-09-15       Impact factor: 3.641

9.  Targeting the fatty acid biosynthesis enzyme, beta-ketoacyl-acyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents.

Authors:  Patricia J Lee; Jayendra B Bhonsle; Heather W Gaona; Donald P Huddler; Tiffany N Heady; Mara Kreishman-Deitrick; Apurba Bhattacharjee; William F McCalmont; Lucia Gerena; Miriam Lopez-Sanchez; Norma E Roncal; Thomas H Hudson; Jacob D Johnson; Sean T Prigge; Norman C Waters
Journal:  J Med Chem       Date:  2009-02-26       Impact factor: 7.446

10.  Novel diaryl ureas with efficacy in a mouse model of malaria.

Authors:  John W Anderson; Dimitri Sarantakis; Jacek Terpinski; T R Santha Kumar; Han-Chun Tsai; Mack Kuo; Arba L Ager; William R Jacobs; Guy A Schiehser; Sean Ekins; James C Sacchettini; David P Jacobus; David A Fidock; Joel S Freundlich
Journal:  Bioorg Med Chem Lett       Date:  2012-12-20       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.